Divani Caravel,
Athens, 09-11/06/2023

IASIS PHARMA participated in the dermatological conference “ATTICA DERMATOLOGY DAYS”, which was held on June 09-11, 2023, at the Divani Caravel hotel /Athens. The conference, which organized by the Hellenic College of Dermatology-Venereology, with the scientific support of the 2^nd Clinic of Dermatology and Venereal Diseases EKPA, mainly concerned at the central position that the specialty of Dermatology-Venereology occupies in the context of Internal Pathology and Medicine in general.

IASIS PHARMA also participated in the conference with a satellite lecture on the topic: “Isotretinoin in the Systemic Treatment of Acne“.

The introductory speaker was Dr. Kanelleas Ant., Academic Scholar, 2^nd University Clinic of Dermatology and Venereal Diseases, P.G.N. “Attikon” and the president was Al. Katoulis Professor of Dermatology – Venereology School of Medicine E.K.P.A., Director of the 2^nd University Clinic of Dermatology and Venereal Diseases, P.G.N. “Atticon”.

The satellite lecture received great acceptance and enthusiasm by the dermatologists because the use of Isotretinoin is a milestone in dermatological therapeutic practice with an extremely successful course for over 40 years.

Additionally, IASIS PHARMA, not only maintains but is also the only pharmaceutical company in Greece that has expanded the already existing dosage range of Isotretinoin (10mg, 20mg) with the unique Isotroin of 30mg & 40mg.

At the IASIS PHARMA exhibition, the following products were presented:

• Isotroin^®/Isotretinoin, indicated for severe forms of acne that are resistant to treatment with systemically administered antibiotics and topical therapy
• Combi^®, a combination of fluprednidene+miconazole cream for the treatment of Inflammatory Dermatomycoses
• Modiwart^®/Ιmiquimod, an innovative modifier of the immune response system indicated for the treatment of: External Genital Warts, Superficial Basal Cell Carcinomas and Aktinic keratoses.